Back to search
Fibrolamellar Hepatocellular Carcinoma (FLC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrolamellar Hepatocellular Carcinoma (FLC) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrolamellar Hepatocellular Carcinoma (FLC) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The aim of this clinical trial is to evaluate the immunogenicity along with safety and toxicity as well as first efficacy of a DNAJB1-PRKACA fusion transcript-b…
The purpose of this study is to determine whether the combination of subcutaneous DRP-104 in combination with intravenous Durvalumab is safe and yields a clinic…
The primary objective of the trial is the safety and tolerability of administering a vaccine targeting the DNAJB1-PRKACA fusion kinase, in combination with nivo…
The purpose of this study is to determine whether the combination of a neoantigen vaccine targeting the DNAJB1-PRKACA fusion kinase in combination with DRP-104,…
The purpose of this study is to collect information about people with fibrolamellar cancer (FLC). This study is a registry of people with FLC around the world.…